INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Sagent Pharmaceuticals...
22 Julio 2016 - 10:48AM
Business Wire
The Law Offices of Vincent Wong are investigating potential
claims against the Board of Directors of Sagent Pharmaceuticals,
Inc. (NASDAQ:SGNT) (“Sagent Pharmaceuticals” or “the Company”) in
connection with the sale of the Company to Nichi-Iko Pharmaceutical
Co., Ltd. Under the terms of the transaction, Sagent
Pharmaceuticals shareholders will receive $21.75 in cash for each
share of Sagent Pharmaceuticals stock they own.
Click here to learn about the case:
http://docs.wongesq.com/SGNT-Info-Request-Form-1278. There
is no cost or obligation to you.
The investigation concerns whether the Board of Sagent
Pharmaceuticals breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Nichi-Iko Pharmaceutical Co.,
Ltd. is underpaying for Sagent Pharmaceuticals shares.
If you own common stock in Sagent Pharmaceuticals and wish to
obtain additional information, please contact Vincent Wong, Esq.
either via email vw@wongesq.com, by telephone at 212.425.1140, or
visit
http://docs.wongesq.com/SGNT-Info-Request-Form-1278.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160722005585/en/
The Law Offices of Vincent WongVincent Wong, Esq.,
212-425-1140Fax. 866-699-3880vw@wongesq.com
Sagent (NASDAQ:SGNT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Sagent (NASDAQ:SGNT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Sagent Pharmaceuticals, Inc. (NASDAQ): 0 recent articles
Más de Sagent Pharmaceuticals, Inc. (MM) Artículos de Noticias